{
    "Trade/Device Name(s)": [
        "MeMed BV",
        "MeMed BV\u00ae",
        "MeMed Key\u00ae",
        "MeMed BV\u00ae Test"
    ],
    "Submitter Information": "MeMed Diagnostics Ltd.",
    "510(k) Number": "K230944",
    "Predicate Device Reference 510(k) Number(s)": [
        "K222332"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QPS"
    ],
    "Summary Letter Date": "April 4, 2023",
    "Summary Letter Received Date": "April 4, 2023",
    "Submission Date": "April 4, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Measure Non-Microbial Analyte(s) In Human Clinical Specimens To Aid In Assessment Of Patients With Suspected Sepsis"
    ],
    "Analyte Class(es)": [
        "immunology",
        "misc"
    ],
    "Analyte(s)": [
        "TRAIL",
        "IP-10",
        "CRP"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Venous Whole Blood"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "MeMed Key\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Automated immunoassay"
    ],
    "Methodologies": [
        "Semi-quantitative immunoassay",
        "Software algorithm-based analysis"
    ],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "Cartridge",
        "Reagent",
        "Calibrator",
        "External Control"
    ],
    "Document Summary": "FDA 510(k) summary for MeMed BV test, an automated semi-quantitative immunoassay measuring TRAIL, IP-10, and CRP in serum and venous whole blood to aid in differentiating bacterial from viral infection.",
    "Indications for Use Summary": "Intended for use as an aid to differentiate bacterial from viral infection in adult and pediatric patients presenting to emergency or urgent care with suspected acute bacterial or viral infection of less than seven days' duration, using serum or venous whole blood samples, in conjunction with clinical assessments and other laboratory findings.",
    "fda_folder": "Microbiology"
}